Exhibit 107
Calculation of Filing Fee Tables
Form S-1
(Form Type)
GreenLight Biosciences Holdings, PBC
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
Security Type | Security Class Title | Fee Calculation or Carry Forward Rule | Amount Registered(1)(2) | Proposed Price Per Unit | Maximum Price | Fee Rate | Amount of Registration Fee | |||||||||||
Newly Registered Securities | ||||||||||||||||||
Fees to Be Paid | Equity | Common stock, par value $0.0001 per share | Other(3) | 28,060,301 | $1.79 | $50,227,939 | $0.0000927 | $4,657 | ||||||||||
Total Offering Amounts | $50,227,939 | $4,657 | ||||||||||||||||
Total Fees Previously Paid | — | — | ||||||||||||||||
Total Fee Offsets | — | — | ||||||||||||||||
Net Fee Due | $4,657 |
(1) | Consists of 28,060,301 shares of common stock, par value $0.0001 per share (the “Common Stock”), registered for sale by the selling securityholders named in this registration statement. |
(2) | Pursuant to Rule 416 under the Securities Act of 1933, as amended (“Securities Act”), this registration statement also covers any additional shares of common stock issuable upon stock splits, stock dividends or other distribution, recapitalization or similar events with respect to the shares of Common Stock being registered pursuant to this registration statement. |
(3) | Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(c) under the Securities Act, and based on the average of the high and low sales price per share of the registrant’s Common Stock on the Global Market of The Nasdaq Stock Market LLC (“Nasdaq”) on September 19, 2022. |
Table 3: Combined Prospectuses
Security Type | Security Class Title | Amount of Securities Previously Registered (1) | Form Type | File Number | Initial Effective Date | |||||
Equity | Common Stock, par value $0.0001 per share (2) | 86,631,958 | S-1 | 333-262574 | February 14, 2022 | |||||
Equity | Common Stock, par value $0.0001 per share (2) | 10,350,000 | S-1 | 333-262574 | February 14, 2022 |
(1) | Consists of (i) 86,631,958 shares of Common Stock registered for sale by the selling securityholders named in the combined prospectus included in this registration statement and (ii) 10,350,000 shares of Common Stock issuable upon exercise of warrants to purchase shares of Common Stock. |
(2) | Pursuant to Rule 416 under the Securities Act, the previous registration statement (File No. 333-262574) also covers any additional shares of common stock issuable upon stock splits, stock dividends or other distribution, recapitalization or similar events with respect to the shares of Common Stock registered pursuant to such registration statement. |